Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 27 clinical trials
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia (ACCESS)

-inflammatory mode of action. An RCT that proves the attenuation of the high inflammatory burden of the host with CAP after addition of clarithromycin in the treatment regimen is missing. This RCT is aiming to

antibiotic therapy
antibiotics
pneumonia
antimicrobial agent
  • 0 views
  • 19 Apr, 2022
  • 7 locations
CLArithromycin Versus AZIthromycin in the Treatment of Mycobacterium Avium Complex (MAC) Lung Infections (CLAZI)

azalide (clarithromycin or azithromycin), rifampicin or rifabutin and ethambutol. For MAC disseminated infections, several studies have compared combinations containing clarithromycin or

clarithromycin 1000 mg
ethambutol
tuberculosis
clarithromycin
azithromycin
  • 252 views
  • 14 Feb, 2022
  • 1 location
Treatment of Selinexor in Combination With Clarithromycin, Pomalidomide and Dexamethasone for Relapsed Refractory Multiple Myeloma Patients (ClaSPd)

The purpose of this study is to determine the efficacy and safety of investigational combination therapy of Selinexor, Clarithromycin, Pomalidomide and Dexamethasone (ClaSPd) for patients with

refractory multiple myeloma
measurable disease
dexamethasone
  • 0 views
  • 21 Mar, 2022
  • 2 locations
ILTHPI - Comparison of Medicament Containing Tetracycline Metronidazole Bismuth Versus Amoxicillin Metronidazole Clarithromycin

treatment of H. pylori in 2017, the first line therapeutic regiment of H. pylori containing Amoxicillin, Clarithromycin, and Metronidazole if the rate of Clarithromycin resistance is below 15%, while the

  • 0 views
  • 30 Apr, 2021
  • 1 location
Helicobacter Pylori Eradication According to DPO-PCR Methods

Clarithromycin-containing triple therapy is still the primary therapy approved by the Korean government. However, studies of antibiotic resistance has shown that regional resistance pattern to

antibiotic therapy
Accepts healthy volunteers
clarithromycin
endoscopy
antibiotics
  • 3 views
  • 15 Feb, 2022
  • 1 location
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab

This is a single-center single-arm phase 2 study in which patients will receive daratumumab in combination with clarithromycin/pomalidomide/dexamethasone (D-ClaPd) until progressive disease (PD

measurable disease
progressive disease
neutrophil count
refractory multiple myeloma
dexamethasone
  • 0 views
  • 19 Jun, 2022
  • 1 location
A Study of Bedaquiline Administered as Part of a Treatment Regimen With Clarithromycin and Ethambutol in Adult Patients With Treatment-refractory Mycobacterium Avium Complex-lung Disease (MAC-LD)

The purpose of the study is to evaluate the efficacy of bedaquiline (BDQ) compared with rifamycin when administered as part of a treatment regimen with clarithromycin (CAM) and ethambutol (EB

  • 0 views
  • 18 Jun, 2022
  • 40 locations
Comparison Between High-dose Amoxicillin Dual Therapy and Pylera Quadruple Therapy in the Treatment of Helicobacter Pylori Infection

regimens, as successful eradication has become less frequent with more prevalent antibiotic resistances. This is the case of clarithromycin and metronidazol, both currently recommended as first-line

adenocarcinoma
Accepts healthy volunteers
endoscopy
gastric adenocarcinoma
antibiotics
  • 0 views
  • 07 Nov, 2021
  • 1 location
Susceptibility Testing Guided Versus Empirical Therapy for Refractory H. Pylori Infection

test will be used to determine the minimum inhibitory concentrations of levofloxacin, tetracycline, rifabutin, and clarithromycin to guide the selection of antibiotics. Treatment regimens and

  • 0 views
  • 03 Feb, 2021
  • 1 location
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients

The purpose of this study is to evaluate the safety and efficacy of BiRd regimen combined with BCMA CAR T cell therapy in newly diagnosed multiple myeloma patients

bcma
lenalidomide
dexamethasone
ejection fraction
  • 5 views
  • 28 Feb, 2022
  • 1 location